Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Event, Trade Show, Webcast

The Medicines Company to Participate in the Chardan 3rd Annual Genetic Medicines Conference

The Medicines Company (NASDAQ:MDCO) announced that it will participate in the Chardan 3rd Annual Genetic Medicines Conference on Tuesday, October 8, 2019, in New York. The Company is scheduled to participate in a "fireside chat" discussion at 8:00 a.m. Eastern Daylight Time.

A live audio webcast will be available on The Medicines Company Investor Relations website and a replay of the presentation will be available within 48 hours of the event.

About The Medicines Company

The Medicines Company (NASDAQ: MDCO) is a biopharmaceutical company with a singular, relentless focus on addressing the greatest global healthcare challenge and burden today ? cardiovascular disease. Our purpose is to halt the deadly progression of atherosclerosis and the cardiovascular risk created by high levels of LDL-C. The Company is headquartered in Parsippany, New Jersey. For more information, please visit www.themedicinescompany.com and follow us on Twitter @MDCONews and LinkedIn.

These press releases may also interest you

at 15:05
The global Addison's disease therapeutics market is expected to grow by USD 191.52 million during 2019-2023, according to the latest market research report by Technavio, progressing at a CAGR of almost 4% during the forecast period. The growth of the...

at 15:05
Takeda Pharmaceuticals U.S.A. (TSE: 4502)  ("Takeda") and MiTest Health LLC ("MiTest"), a pioneering health technology company, today announced an exclusive partnership to optimize MiTest's personalized risk and outcome prediction tool for widespread...

at 14:55
Eagle Pharmaceuticals, Inc. ("Eagle" or the "Company") today announced that it has reached a settlement agreement with Eli Lilly and Company ("Lilly") related to the Company's novel product, PEMFEXYtm (pemetrexed for injection), a branded...

at 14:27
Mimi's Rock Corp. ("Mimi's Rock" or the "Company") is pleased to announce the successful completion of its previously-announced acquisition of All Natural Advice Ltd. ("All Natural") and Maritime Naturals Ltd. ("Maritime Naturals") by way of a share...

at 14:07
ITF Pharma, a U.S.-based specialty pharmaceutical company and subsidiary of Italfarmaco, a privately-held European specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved its application to...

at 14:05
Synedgen, a biotechnology company using glycochemistry to develop drugs that enhance and mimic the innate immune system, today announced the award of a competitive Congressionally Directed Medical Research Program (CDMRP) contract. Administered...

News published on 4 october 2019 at 11:05 and distributed by: